Key Metrics of Alpha Pro Tech Ltd.
Revenue$61.2M▼ 1.2% YoYFY 2023
Operating income$4.1M▼ 11.1% YoY
Net profit$4.2M▲ 28.0% YoY
Shareholders' equity$61.6M
Market cap$55.5MAPT · $5.44
Competitors10identified
About Alpha Pro Tech Ltd.
Sectors
Company details
- Founded
- 2000
- Listed
- NYSE: APT (since 2000)
Operational Areas of Alpha Pro Tech Ltd.
Pharmaceuticals & Healthcare›Biotechnology & Vaccines
Company summary
Legal nameAlpha Pro Tech Ltd.
TickerAPT
ExchangeNYSE
CountryCanada
SEC CIK0000884269
Listed since2000
IndustryIndustrial Specialties
SectorPharmaceuticals & Healthcare · Biotechnology & Vaccines
Website—
US market & SEC filings
APT · NYSE · SEC CIK 0000884269
Last price · 28 Oct 2026
$5.44
−2.16%
Market cap$55.5M
P/E15.5On FY 2023 diluted EPS
Volume27,420
SectorHealth CareIndustrial Specialties
Country · IPOCanadaListed 2000
APT share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered office—
GSTIN—
Email—
Website—
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Alpha Pro Tech Ltd.
Competitors10identified
Countries2most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Part of Vertex Pharmaceuticals. | vrtx.com | 1991 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | gsk.com | 2022 | United Kingdom | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | modernatx.com | 2018 | United States | |
 Becton Dickinson |
Biotechnology & Vaccines · Pharmaceuticals & Healthcare | bd.com | — | United States |
| Part of Illumina. | illumina.com | 2000 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | guardanthealth.com | 2018 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | revvity.com | — | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | exelixis.com | 2000 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | neurocrine.com | 1996 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | biomarin.com | 1999 | United States |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.
Filings
No filings on record yet.